# Trade Mark Journal No.2025/042 17 October 2025

## WO0000001878483 (5)

Office of origin: United States of America

Date of International Registration:5 September 2025
Date of designation in the UK: 5 September 2025

International priority date claimed: 30 April 2025 (United States of America) (99164118)

Class 5
  Pharmaceutical formulation for transcutaneous drug delivery for the treatment of skin conditions and wounds.

Christopher Otiko

Representative: Kimberly Bullock Gatling Fox Rothschild LLP, 212 Carnegie Center Drive, Suite 400, Princeton NJ 08540, UNITED STATES OF AMERICA